Literature DB >> 15758334

Introduction--Bone turnover and fracture risk.

D B Burr1.   

Abstract

Entities:  

Year:  2003        PMID： 15758334

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN： 1108-7161            Impact factor:   2.041


× No keyword cloud information.
  3 in total

1.  Timing of androgen deprivation therapy use and fracture risk among elderly men with prostate cancer in the United States.

Authors:  Jennifer L Beebe-Dimmer; Karynsa Cetin; Vahakn Shahinian; Hal Morgenstern; Cecilia Yee; Kendra L Schwartz; John Acquavella
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-11-24       Impact factor: 2.890

Review 2.  Bone turnover markers: understanding their value in clinical trials and clinical practice.

Authors:  R Civitelli; R Armamento-Villareal; N Napoli
Journal:  Osteoporos Int       Date:  2009-02-04       Impact factor: 4.507

3.  Androgen-deprivation therapy and the risk of newly developed fractures in patients with prostate cancer: a nationwide cohort study in Korea.

Authors:  Do Kyung Kim; Hye Sun Lee; Ju-Young Park; Jong Won Kim; Hyun Kyu Ahn; Jee Soo Ha; Kang Su Cho
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.